Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
NET REVENUE $ 38,304,000 $ 31,639,000 $ 102,137,000 $ 73,085,000
OPERATING EXPENSES:        
Direct operating costs 24,124,000 19,718,000 62,719,000 45,842,000
Selling and marketing 2,375,000 1,571,000 6,469,000 4,778,000
General and administrative 5,921,000 6,191,000 17,814,000 17,176,000
Research and development 488,000 2,367,000 4,328,000 6,846,000
Change in contingent consideration (500,000) (500,000)
Depreciation and amortization 3,547,000 3,206,000 9,505,000 6,944,000
Loss on lease termination, impairment and unoccupied lease charges 424,000 321,000 1,664,000 681,000
Total operating expenses 36,879,000 32,874,000 102,499,000 81,767,000
OPERATING INCOME (LOSS) 1,425,000 (1,235,000) (362,000) (8,682,000)
OTHER:        
Interest income 4,000 2,000 10,000 44,000
Interest expense (91,000) (132,000) (274,000) (396,000)
Other (expense) income - net (65,000) (246,000) (80,000) 84,000
INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES 1,273,000 (1,611,000) (706,000) (8,950,000)
Income tax (benefit) provision (232,000) 62,000 (20,000) 18,000
NET INCOME (LOSS) 1,505,000 (1,673,000) (686,000) (8,968,000)
Preferred stock dividend 3,642,000 4,230,000 10,408,000 10,150,000
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (2,137,000) $ (5,903,000) $ (11,094,000) $ (19,118,000)
Net loss per common share: basic and diluted $ (0.15) $ (0.46) $ (0.77) $ (1.53)
Weighted-average common shares used to compute basic and diluted loss per share 14,737,103 12,771,307 14,419,968 12,493,458
NET INCOME (LOSS) $ 1,505,000 $ (1,673,000) $ (686,000) $ (8,968,000)
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX        
Foreign currency translation adjustment (a) [1] (475,000) 282,000 (535,000) (292,000)
COMPREHENSIVE INCOME (LOSS) $ 1,030,000 $ (1,391,000) $ (1,221,000) $ (9,260,000)
[1] No tax effect has been recorded as the Company recorded a valuation allowance against the tax benefit from its foreign currency translation adjustments.